InsidersTradesSigma
Discover the detailed record of transactions filed by Paull Robert Bradley, Director. Insider active across 1 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been published. The latest transaction was filed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Robert Bradley Paull is a Director at Kala Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector and understanding of market challenges allow him to provide valuable insights during board discussions.